Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
- PMID: 9005747
- DOI: 10.7326/0003-4819-126-2-199701150-00006
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
Abstract
Background: Loading doses of warfarin that are larger than those used for maintenance therapy are widely used in clinical practice, but they have never been prospectively evaluated.
Objective: To compare the effect of 5- and 10-mg loading doses of warfarin on laboratory markers of warfarin's anticoagulant effect.
Design: Randomized clinical trial.
Setting: Tertiary care teaching hospital.
Patients: 49 patients seen over a 5-month period with a target international normalized ratio (INR) of 2.0 to 3.0.
Intervention: Patients were randomly assigned to receive an initial dose of 5 or 10 mg of warfarin. Subsequent doses of warfarin were administered on the basis of dosing nomograms.
Measurements: INRs and levels of factors II, VII, IX, and X and protein C were measured daily for 5 days.
Results: 11 of 25 patients in the 10-mg group (44% [95% CI, 34% to 54%]) and 2 of 24 patients in the 5-mg group (8% [CI, 3% to 14%]) had INRs greater than 2.0 at 36 hours (P = 0.005), at which time the factor VII levels were 27% (CI, 18% to 36%) in the 10-mg group and 54% (CI, 43% to 65%) in the 5-mg group (P < 0.001). In contrast, factor II levels were 74% (CI, 67% to 81%) in the 10-mg group and 82% (CI, 73% to 93%) in the 5-mg group (P > 0.2). At 60 hours, 9 of 25 patients in the 10-mg group (36% [CI, 17% to 54%]) and no patients in the 5-mg group had INRs greater than 3.0. At 84 hours, 15 of 24 patients in the 10-mg group (63% [CI, 43% to 81%]) and 19 of 24 patients in the 5-mg group (79% [CI, 62% to 95%]) had INRs between 2.0 and 3.0. Four patients in the 10-mg group and 1 patient in the 5-mg group received vitamin K for excessive prolongation of the INR.
Conclusions: A 5-mg loading dose of warfarin produces less excess anticoagulation than does a 10-mg loading dose; the smaller dose also avoids the development of a potential hypercoagulable state caused by precipitous decreases in levels of protein C during the first 36 hours of warfarin therapy.
Comment in
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. doi: 10.7326/0003-4819-127-4-199708150-00015. Ann Intern Med. 1997. PMID: 9265436 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. doi: 10.7326/0003-4819-127-4-199708150-00016. Ann Intern Med. 1997. PMID: 9265437 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. Ann Intern Med. 1997. PMID: 9265438 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332-3. Ann Intern Med. 1997. PMID: 9265439 No abstract available.
-
Randomized trial of warfarin nomograms.Ann Intern Med. 2004 Mar 16;140(6):489-90; author reply 491-2. doi: 10.7326/0003-4819-140-6-200403160-00026. Ann Intern Med. 2004. PMID: 15023723 No abstract available.
-
Randomized trial of warfarin nomograms.Ann Intern Med. 2004 Mar 16;140(6):491; author reply 491-2. doi: 10.7326/0003-4819-140-6-200403160-00029. Ann Intern Med. 2004. PMID: 15023726 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical